21 November 2017
News and Views
Links and Services
A study in the latest issue of Gastroenterology investigates the risk of nonmelanoma skin cancers in patients who receive thiopurines for IBD.
There are limited data on the risk of nonmelanoma skin cancer (NMSC) among individuals with infla
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors